Current evidence suggests that patients losing weight should consume adequate protein daily, with targets typically ranging from 1.21.6 grams of protein per kilogram of body weight, individualized based on age, activity level, and kidney function
Future Research Directions and Emerging Applications Systemic Administration and Biodistribution Studies While most clinical applications of GHK-Cu involve topical administration, emerging research explores systemic delivery routes including subcutaneous injection, intravenous infusion, and oral administration for potential applications in systemic inflammation, tissue remodeling, and age-related decline
Some patients may experience shifts in blood sugar, joint stiffness, or fatigue, which is why regular followup and dose adjustments are important
Resnick E, Shteingart S, Melamud B, Bdolah-Abram T, Zalut T, Reuben A, Lurie Y